Abstract

Enhancement of hematopoietic stem cell (HSC) homing and engraftment is clinically critical, especially for cord blood (CB) hematopoietic cell transplantation. Here we report that specific HDAC5 inhibition highly upregulates CXCR4 surface expression in human CB HSCs and progenitor cells (HPCs). This results in enhanced SDF-1/CXCR4-mediated chemotaxis and increased homing to the bone marrow environment, with elevated SCID-repopulating cell (SRC) frequency and enhanced long-term and secondary engraftment in NSG mice. HDAC5 inhibition increases acetylated p65 levels in the nucleus, which is important for CXCR4 transcription. Inhibition of nuclear factor-κB (NF-κB) signaling suppresses HDAC5-mediated CXCR4 upregulation, enhanced HSC homing, and engraftment. Furthermore, activation of the NF-κB signaling pathway via TNFα also results in significantly increased CXCR4 surface expression, enhanced HSC homing, and engraftment. These results demonstrate a previously unknown negative epigenetic regulation of HSC homing and engraftment by HDAC5, and allow for a new and simple translational strategy to enhance HSC transplantation.

Highlights

  • Enhancement of hematopoietic stem cell (HSC) homing and engraftment is clinically critical, especially for cord blood (CB) hematopoietic cell transplantation

  • We demonstrate that specific HDAC5 inhibition leads to upregulation of C-X-C receptor-4 (CXCR4) surface expression in human CB HSCs and HSCs and progenitor cells (HPCs)

  • Activation of the nuclear factor-κB (NF-κB) signaling pathway via tumor necrosis factor-α (TNFα) results in significantly increased CXCR4 surface expression and enhanced HSC homing. These results suggest that HDAC5 negatively regulates CXCR4 transcription and HSC homing via p65 acetylation

Read more

Summary

Introduction

Enhancement of hematopoietic stem cell (HSC) homing and engraftment is clinically critical, especially for cord blood (CB) hematopoietic cell transplantation. B Histogram of surface CXCR4 expression of human CB CD34+ cells treated with vehicle or HDAC inhibitor M344. D Confocal imaging analysis of surface CXCR4 expression of human CB CD34+ cells treated with vehicle or M344.

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call